Key result
Helix locking tool during LBBP is linked to ~91% procedural success without acute adverse events.
Why the study?
Helix retraction during septal lead deployment can complicate LBBP procedures with extendable-retractable helix leads, but clinical performance data on a novel helix locking tool remain limited.
Observational (n=87)
Yes
The use of a helix locking tool during left bundle branch pacing with a stylet-driven lead is safe and associated with high procedural success without helix retraction.
Answers are grounded in this paper and cite their sources.
May facilitate LBBP by reducing helix retraction; hypothesis-generating pending randomized confirmation.
PURPOSE Helix retraction during septal lead deployment can complicate left bundle branch pacing (LBBP) procedures performed with extendable-retractable helix leads. A helix locking tool (HLT) has been developed to stabilize the helix of a stylet-driven lead during implantation, but clinical performance data remain limited. This study aimed to evaluate the acute safety and procedural performance of this tool in a multicenter setting. METHODS In this prospective multicenter registry, 87 consecutive patients who underwent LBBP were enrolled in eight centers in Spain. Implantation was performed using a stylet-driven Tendril STS lead and CPS Direct 3D sheath, with the HLT used during septal deployment. The primary endpoint was freedom from acute adverse events related to the HLT. Secondary endpoints included procedural success, lead repositioning, and acute electrical parameters. RESULTS LBBP was successfully achieved in 79 of 87 patients (90.8%). Lead repositioning was required in 36 cases (41.4%), with a mean of 2.3 ± 1.3 attempts. No cases of helix retraction were observed. Three intraprocedural lead dislodgements (3.4%) occurred and were managed without clinical consequences. No acute complications related to the HLT were reported. Electrical parameters were compatible with conduction system capture. CONCLUSIONS In this prospective multicenter registry, left bundle branch capture was achieved in 79 of 87 patients (90.8%). No helix retraction or acute adverse events considered related to the HLT by site investigators were observed during 24-hour follow-up. In the absence of a comparator group, the study cannot determine whether the HLT reduces helix retraction or improves procedural outcomes.
No takes yet. Share an insight, caveat, or question.
Menéndez et al. (2026) conducted an observational in Bradycardia or heart failure requiring cardiac device implantation (n=87). Helix locking tool (HLT) was evaluated on Freedom from acute adverse events related to the HLT during the procedure or within 24 hours after implantation. The use of a helix locking tool during left bundle branch pacing was associated with a 90.8% procedural success rate, complete absence of helix retraction, and no tool-related acute adverse events.
Synapse has enriched 10 related papers. Consider them for comparative context: